fenofibrate
AssetSmall moleculeAlso HL-PIF, Fenofibrate /Metformin, Fenofibrate/CoQ10, Fenofibrate/Simvastatin
PPAR alpha agonist regulating lipid metabolism
- Stage
- Approved
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- Indications
- 17
- Trials
- 92
- Developers
- 4
Indications
17Dyslipidemia
Approvedaccessdata.fda.gov7 Oct 2026
Hypercholesterolemia
Approvedaccessdata.fda.gov7 Oct 2026
Hyperlipidemia
Approvedaccessdata.fda.gov7 Oct 2026
14 more
- Targets and what it contains2
- Owner and partners4
- Trials92
- Evidence for its targets3
- Competitors12
- Aging relevance1
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 25 sources